Vimarsana
Biggest News Aggregation in the World

Page 2 - Stephen Bancel News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Stephen Bancel. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Stephen Bancel Today - Breaking & Trending Today

Pfizer CEO unsure on need for fourth dose of COVID-19 vaccine - Vimarsana News

Pfizer CEO unsure on need for fourth dose of COVID-19 vaccine

Pfizer Chief Executive Officer Albert Bourla said on Monday he was unsure about the need for a fourth dose of COVID-19 vaccine and that a shot targeting the highly contagious Omicron variant would be ready in March.\n\n

Source: ksl.com
Pfizer CEO unsure on need for 4th dose of COVID-19 vaccine - Vimarsana News

Pfizer CEO unsure on need for 4th dose of COVID-19 vaccine

Pfizer Chief Executive Officer Albert Bourla said on Monday he was unsure about the need for a fourth dose of COVID-19 vaccine and that a shot targeting the highly contagious Omicron variant would be ready in March.\n\n

Source: ksl.com
[Reporter's notebook] Moon shirking responsibility on infection surge, slow vaccination - Vimarsana News

[Reporter's notebook] Moon shirking responsibility on infection surge, slow vaccination

[Reporter's notebook] Moon shirking responsibility on infection surge, slow vaccination

Australia Is Set To Get 25 Million Doses Of The Moderna COVID-19 Vaccine, But When? - Vimarsana News

Australia Is Set To Get 25 Million Doses Of The Moderna COVID-19 Vaccine, But When?

Australia Is Set To Get 25 Million Doses Of The Moderna COVID-19 Vaccine, But When? Share Getty Images Australia’s terribly slow vaccine rollout is about to get a boost. The federal government has agreed to purchase 25 million doses of the Moderna COVID-19 vaccine, which should start to arrive later this year. The Moderna vaccine still needs to be approved by Therapeutic Goods Association (TGA) for use in Australia. Once approved it should hopefully help to fill the gap left by Astra Zeneca for those in the under 50s age group. What is the Moderna vaccine? Moderna’s COVID-19 vaccine is an...

Moderna COVID-19 Booster: Effective Protection Against New Variants, Early Clinical Trial Shows - Vimarsana News

Moderna COVID-19 Booster: Effective Protection Against New Variants, Early Clinical Trial Shows

Close An early clinical trial recently showed that the new Moderna COVID-19 booster could be an effective shield against the variants of coronavirus originally found in South Africa and Brazil. According to ScienceAlert, the American biotech company began to develop "variant-specific boosters" earlier this year after evidence that several variants of COVID-19 can break through present vaccines. This is Moderna's pioneering clinical trial in humans, following early trials on mice, and so far, the results are found promising. Stephen Bancel, Moderna CEO said in a press release the company poste...